|
| Research progress in targeted therapy of non-small cell lung cancer with traditional Chinese medicine to “attenuate toxicity and enhance efficacy” |
| Hits 1186 Download times 799 Received:October 30, 2019 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1672-1519.2020.03.25 |
| Key Words
traditional Chinese medicine;targeted therapy;non-small cell lung cancer;attenuate toxicity;enhance efficacy |
| Author Name | Affiliation | E-mail | | LI Xiaojiang | Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China | | | GUO Jingyao | Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | | | GUO Shanqi | Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China | | | LIU Honggen | Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China | | | MOU Ruiyu | Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | | | LIU Xiaodi | Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | | | LI Wenjie | Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | | | SONG Bo | Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | | | ZHANG Chang | Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | | | WANG Linhuan | Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | | | JIA Yingjie | Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China | jiayingjie1616@sina.com |
|
| Abstract
|
| The treatment of lung cancer has entered the era of individualized precision therapy. Targeted therapy has become the first choice of treatment for patients with advanced non-small-cell lung cancer (NSCLC) and has significant clinical benefits. With the expansion of the application of targeted drugs in recent years,the emergence of adverse reactions and drug resistance have restricted the treatment process and clinical efficacy to a certain extent. At present,the treatment of lung cancer with integrated traditional Chinese and western medicine has become one of the current research hotspots. A number of studies have shown that the combination of traditional Chinese medicine and targeted therapy is effective in the occurrence of adverse reactions,improvement of life quality and drug resistance. This paper will further summarize the research on the combination of traditional Chinese medicine and targeted therapy in the field of lung cancer,in order to provide more theoretical basis for clinical treatment. |
|
|
|
|
|
|
|
